Delayed diagnosis of axSpA has a detrimental impact on life quality
Research shows an average delay in the diagnosis of axial spondyloarthritis (axSpA) of around 7 years – and up to 15 years in some cases – during which time the condition can progress and lead to irreversible damage. At the EULAR2021, Dr Dale Webb and colleagues call for action upon the world-wide delay in diagnosis supported by comprehensive data on stakeholder experiences and new recommendations in order to transform the landscape of axSpA care.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.